Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1988-12-07
1990-01-02
Siegel, Alan
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514469, 549 57, 549468, A61K 31385, C07D33356, C07D30778
Patent
active
048913839
ABSTRACT:
New original derivatives are described of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4-oxobutanoic acids having the formula: ##STR1## in which n is 1 or 2, R.sub.1 is selected from the groups 2-naphthyl, 2 (or 3)-quinolinyl, 2 (or 3)-indolyl, 2 (or 3)-benzofuranyl, 2 (or 3)-benzothiophenyl, and R.sub.2 is a pentyl group or an alkoxyalkyl group with 4 or 5 carbon atoms, preferably pentyl, 2-ethoxyethyl, 3-methoxypropyl or 3-ethoxypropyl.
The compounds have a powerful antagonistic activity towards cholecystokinin and are particularly useful in the treatment of illnesses of the digestive system, such as colitis, biliary diskinesia, pancreatisis or in the treatment of disorders of the central nervous system imputable to deficiencies in the physiological neuron levels of cholecystokinin or other related bioactive polypeptides.
REFERENCES:
patent: 4808599 (1989-02-01), Dubroeucq et al.
patent: 4826878 (1989-05-01), Makovec et al.
Chiste Rolando
Makovec Francesco
Peris Walter
Rovati Luigi
Rotta Research Laborarorium S.p.A.
Siegel Alan
LandOfFree
Derivatives of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4- does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Derivatives of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4-, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Derivatives of 5-pentylamino-5-oxopentanoic and 4-pentylamino-4- will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1383965